Avalo Therapeutics Inc
F:C6K
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avalo Therapeutics Inc
F:C6K
|
US |
|
Dian Swastatika Sentosa Tbk PT
IDX:DSSA
|
ID |
|
Daimler Truck Holding AG
F:DTG1
|
DE |
|
F
|
Future Enterprises Ltd
NSE:FELDVR
|
IN |
|
Stora Enso Oyj
OTC:SEOJF
|
FI |
|
Anoto Group AB
STO:ANOT
|
SE |
|
N
|
Nissin Foods Holdings Co Ltd
XBER:NF2
|
JP |
|
S
|
Sprouts Farmers Market Inc
F:1FA
|
US |
|
Blue Hat Interactive Entertainment Technology
F:4Y80
|
CN |
|
UOB-Kay Hian Holdings Ltd
SGX:U10
|
SG |
|
Andritz AG
OTC:ADRZY
|
AT |
|
W
|
WEG SA
F:B7F0
|
BR |
|
D
|
Dagang NeXchange Bhd
KLSE:DNEX
|
MY |
|
clearvise AG
F:ABO
|
DE |
|
S
|
Sprouts Farmers Market Inc
SWB:1FA
|
US |
|
Nanophase Technologies Corp
NASDAQ:SLSN
|
US |
|
M
|
Magnis Energy Technologies Ltd
F:U1P
|
AU |
|
Margaret Lake Diamonds Inc
XTSX:DIA
|
CA |
|
B
|
Banca Popolare Di Sondrio SpA
SWB:593
|
IT |
|
F
|
First National Corp
NASDAQ:FXNC
|
US |
|
Digipath Inc
OTC:DIGP
|
US |
|
D
|
Danaher Corp
F:DAP
|
US |
|
F
|
First Commonwealth Financial Corp
F:FCF
|
US |
|
C
|
Caspian Sunrise PLC
OTC:ROXIF
|
UK |
Bankruptcy Probability
Avalo Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Avalo Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Avalo Therapeutics Inc
NASDAQ:AVTX
|
954.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
447.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Avalo Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Avalo Therapeutics Inc has total debt of 2m USD. This includes both short-term (0 USD) and long-term (2m USD) debt.
You can find a full breakdown on its Balance Sheet.